SLIDESHOW: Showcasing Melanoma Research at the 56th Annual ACMS Meeting
Dozens of investigators shared findings to advance care in patients with melanoma during Mohs micrographic surgery.
References
- Badin D, Salem I, Feng J, et al.Analyzing rate of recurrences and new primary melanotic malignancies post melanoma in situ diagnosis: findings from a single-center study. Poster presented at: 56th Annual ACMS Meeting. May 2-5, 2024; Phoenix, AZ.
- Juhasz M, Gharavi N. Cutaneous melanoma upstaging during Mohs micrographic surgery. Poster presented at: 56th Annual ACMS Meeting. May 2-5, 2024; Phoenix, AZ.
- Read C, Armstrong A. Factors that impact patients’ satisfaction with their dermatological surgeons: a population study among u.s. adults with melanoma and non-melanoma cutaneous cancers who underwent a surgical procedure. Poster presented at: 56th Annual ACMS Meeting. May 2-5, 2024; Phoenix, AZ.
- Moody B, Sudhaman S, Ferguson J, et al. Feasibility of using a tumor-informed circulating tumor DNA (ctDNA) test for clinical decision-making in patients with resectable stage II/III melanoma. Poster presented at: 56th Annual ACMS Meeting. May 2-5, 2024; Phoenix, AZ.
- Asamoah E, Demer A, Vidal N, et al. Immunohistochemistry-assisted Mohs surgery for treatment of invasive eyelid and periorbital cutaneous melanoma: oncologic and reconstructive outcomes. Poster presented at: 56th Annual ACMS Meeting. May 2-5, 2024; Phoenix, AZ.
- DaCunha M, Coldiron B, Tassavor M, Bland M. Improving melanoma reporting adherence: the melanoma reporting model. Poster presented at: 56th Annual ACMS Meeting. May 2-5, 2024; Phoenix, AZ.
- Campbell E, Reinhart J, Proffer S, et al. Incidence and mortality trends of primary cutaneous melanoma: a 50-year population-based study. Poster presented at: 56th Annual ACMS Meeting. May 2-5, 2024; Phoenix, AZ.
- Freeman S, Carr D, Shahwan K, Latour E, Leitenberger J. Margin assessment in Mohs for melanoma: evaluation of interrater and intrarater reliability. Poster presented at: 56th Annual ACMS Meeting. May 2-5, 2024; Phoenix, AZ.